Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

Despite changed guidelines, a new study has found that misconceptions about eggs and cholesterol may still be keeping people ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

February is American Heart Month—a perfect opportunity for members of the George Washington University community to take a ...